Site content is prepared and reviewed under the supervision of Prof. Dr. Burak Tatlı (Paediatric Neurologist).
Health article

22q11.2 guide: from multisystem follow-up to prognosis and mental health

7 October 2026·Prof. Dr. Burak Tatlı
22q11.2 guide: from multisystem follow-up to prognosis and mental health

Overview

22q11.2 deletion syndrome (~1/4,000) is the most common microdeletion in humans and a "single diagnosis, many specialties" condition: the heart, calcium, immunity, palate-speech, learning and mental health all come together in the same patient file. A well-established follow-up schedule turns scattered problems into a manageable plan.

Genetic Cause

Deletion of ~40 genes, including TBX1, on chromosome 22. ~90% of cases are de novo; in close to 10% a parent is also a carrier (most are mildly affected and undiagnosed) → parental testing is essential; a carrier parent's risk of passing it to a subsequent child is 50%. Diagnosis is made by microarray/MLPA; it can also be picked up on NIPT screening.

Clinical Features — What Stands Out by Age

Newborn-infancy

Preschool-school age

Adolescence-adulthood

Follow-up Schedule (summary)

Treatment

Prognosis — An Honest Framework

Research Horizon

Daily Life

The content of this site is for information only; please consult your own physician for diagnosis and treatment decisions.